Fatima Brant Selected Research

Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)

1/2015

Phosphatidylinositol 3-Kinase γ is required for the development of experimental cerebral malaria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fatima Brant Research Topics

Disease

3	Parasitemia 05/2016 - 07/2012
2	Cerebral Malaria 05/2016 - 01/2015
2	Infections 05/2016 - 08/2014
2	Inflammation (Inflammations) 08/2014 - 01/2012
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2019
1	Chagas Disease (American Trypanosomiasis) 01/2012

Drug/Important Bio-Agent (IBA)

3	Interleukin-6 (Interleukin 6)IBA 05/2016 - 07/2012
2	CytokinesIBA 01/2019 - 05/2016
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2016
2	Interleukin-17 (Interleukin 17)IBA 05/2016 - 08/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2014 - 07/2012
1	Interleukin-12 (IL 12)IBA 05/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2016
1	Hormones (Hormone)IBA 05/2016
1	Nerve Growth Factors (Neurotrophins)IBA 05/2016
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 05/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2015
1	Interferon-gamma (Interferon, gamma)IBA 08/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 08/2014
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 08/2014
1	InterferonsIBA 07/2012
1	Interleukin-10 (Interleukin 10)IBA 07/2012
1	VaccinesIBA 01/2012